CD33 and dementia: Elizabeth Bradshaw, PhD (Columbia University) discussed how big data approaches are being translated to address the complexities of microglia phenotypes based on one’s genetic background using the example of the CD33 genetic risk allele’s mechanism of action on CD33 and its binding partners to identify novel therapeutic targets in dementia.